Latest news with #Investing
Yahoo
4 hours ago
- Business
- Yahoo
Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com
Aurora Cannabis (ACB) announced that it has become aware of 'a second instance of misinformation' posted on news website On June 18, Aurora advised the market that an article posted on incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, a second article was posted on that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for distribution of medical cannabis in Germany and other EU markets. 'The company categorically denies both articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm GmbH with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions. The erroneous articles posted on state that they were generated 'with the support of AI' and reviewed by an editor. The company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that should not be considered a credible source of information regarding the company. Any information regarding material corporate transactions will be announced directly by the company to the market as soon as it is appropriate to do so,' Aurora stated. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ACB: Disclaimer & DisclosureReport an Issue Aurora Cannabis Reports Record Revenue and Growth Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics Aurora Cannabis denies acquisition of MedLeaf Therapeutics Morning Movers: Circle rises following regulatory framework for stablecoins Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
15 hours ago
- Business
- Globe and Mail
Aurora Cannabis Advises of Second False Article from Investing.com
NASDAQ| TSX: ACB EDMONTON, AB, June 19, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on news website,
Yahoo
21 hours ago
- Business
- Yahoo
Aurora Cannabis confirms AI-generated news reports of $215M deal and new partnership are 'entirely false'
Aurora Cannabis ( has confirmed multiple AI-generated news reports published online Wednesday are false. One of the articles, published on the website claimed the Canadian pot company is acquiring a New Zealand-based cannabis producer in a $215 million cash and stock deal. Another report on the same site announced a new partnership to distribute medical cannabis in Europe. Both links were taken down as of Thursday afternoon. 'Neither of these stories are true in any way. This is entirely false information,' Aurora's vice-president of communications and public relations Michelle Lefler stated in an email to Yahoo Finance Canada on Thursday. 'I can confirm we take this situation very seriously and are taking the appropriate actions.' Toronto-listed Aurora shares fell more than 20 per cent on Wednesday, despite the Edmonton-based company reporting strong financial results in its most recent quarter before the opening bell. Shares fell about four per cent on Thursday, hitting their lowest level since April. A story posted on the website on Wednesday said Aurora 'announced today the acquisition of MedLeaf Therapeutics, a specialized medical cannabis producer, for $215 million in a cash and stock transaction.' The article, which said it was generated with the support of artificial intelligence and reviewed by an editor, quotes Aurora CEO Miguel Martin, and cites filings with the U.S. Securities and Exchange Commission (SEC). "The company has not entered into any such agreement, has had no discussions with MedLeaf Therapeutics with respect to any business combination transaction, and has not made any statement or filed any information pertaining to any such transaction," Aurora stated in a news release. A separate article on published Wednesday, which also quoted Martin and cited SEC filings, referenced a new strategic partnership between Aurora and European pharmaceutical distributor MediPharm GmbH to expand its medical cannabis presence in Germany and other EU markets. "Aurora has issued two press releases in the last 24 hours denouncing any information listed on Lefler added in her email on Thursday. An spokesperson confirmed the content was removed in an email to Yahoo Finance Canada on Thursday. 'The articles in question were published due to a technical issue and were immediately removed upon receiving notice," the spokesperson wrote. Jeff Lagerquist is a senior reporter at Yahoo Finance Canada. Follow him on X @jefflagerquist. Download the Yahoo Finance app, available for Apple and Android. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
a day ago
- Business
- Yahoo
Aurora Cannabis says AI-generated news reports of $215M deal and new partnership are 'entirely false'
Aurora Cannabis ( is denying the validity of multiple news reports published on Wednesday. One claims the Canadian pot company is acquiring a New Zealand-based cannabis producer in a $215 million cash and stock deal. Another announces a partnership to distribute medical cannabis in Europe. 'Neither of these stories are true in any way. This is entirely false information,' Aurora's vice-president of communications and public relations Michelle Lefler stated in an email to Yahoo Finance Canada on Thursday. 'I can confirm we take this situation very seriously and are taking the appropriate actions.' Toronto-listed Aurora shares fell more than 20 per cent on Wednesday, despite the Edmonton-based company reporting strong financial results in its most recent quarter before the opening bell. A story posted on the website says Aurora 'announced today the acquisition of MedLeaf Therapeutics, a specialized medical cannabis producer, for $215 million in a cash and stock transaction.' The article, which says it was generated with the support of artificial intelligence and reviewed by an editor, quotes Aurora CEO Miguel Martin, and cites filings with the U.S. Securities and Exchange Commission (SEC). A separate article appearing on published Wednesday, also quoting Martin and citing SEC filings, references a new strategic partnership between Aurora and European pharmaceutical distributor MediPharm GmbH to expand its medical cannabis presence in Germany and other EU markets. More to follow. Jeff Lagerquist is a senior reporter at Yahoo Finance Canada. Follow him on X @jefflagerquist. Download the Yahoo Finance app, available for Apple and Android.
Yahoo
a day ago
- Business
- Yahoo
Aurora Cannabis says AI-generated news reports of $215M deal and new partnership are 'entirely false'
Aurora Cannabis ( is denying the validity of multiple news reports published on Wednesday. One claims the Canadian pot company is acquiring a New Zealand-based cannabis producer in a $215 million cash and stock deal. Another announces a partnership to distribute medical cannabis in Europe. 'Neither of these stories are true in any way. This is entirely false information,' Aurora's vice-president of communications and public relations Michelle Lefler stated in an email to Yahoo Finance Canada on Thursday. 'I can confirm we take this situation very seriously and are taking the appropriate actions.' Toronto-listed Aurora shares fell more than 20 per cent on Wednesday, despite the Edmonton-based company reporting strong financial results in its most recent quarter before the opening bell. A story posted on the website says Aurora 'announced today the acquisition of MedLeaf Therapeutics, a specialized medical cannabis producer, for $215 million in a cash and stock transaction.' The article, which says it was generated with the support of artificial intelligence and reviewed by an editor, quotes Aurora CEO Miguel Martin, and cites filings with the U.S. Securities and Exchange Commission (SEC). A separate article appearing on published Wednesday, also quoting Martin and citing SEC filings, references a new strategic partnership between Aurora and European pharmaceutical distributor MediPharm GmbH to expand its medical cannabis presence in Germany and other EU markets. More to follow. Jeff Lagerquist is a senior reporter at Yahoo Finance Canada. Follow him on X @jefflagerquist. Download the Yahoo Finance app, available for Apple and Android. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
